The Proton Pump Inhibitors (PPIs) market is estimated to be valued at US$ 2.9 billion in 2023 and is expected to exhibit a CAGR of 4.30% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Proton pump inhibitors are a class of drugs that reduce the production of stomach acid. These drugs are primarily used for the treatment of ... Read more

Proton pump inhibitors are drugs that work by reducing the amount of acid produced in the stomach. They are used to treat acid reflux, ulcers, and other conditions caused by excess stomach acid. Some common PPI medications include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. PPIs provide effective relief from symptoms of acid-related disorders and allow stomach ulcers to heal. Their effectiveness and safety profile have led to widespread use for conditions like ... Read more